AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Harpole, DH Moore, MB Herndon, JE Aloia, T D'Amico, TA Sporn, T Parr, A Linoila, I Allegra, C
Citation: Dh. Harpole et al., The prognostic value of molecular marker analysis in patients treated withtrimodality therapy for esophageal cancer, CLIN CANC R, 7(3), 2001, pp. 562-569

Authors: Aloia, TA Harpole, DH Reed, CE Allegra, C Moore, MBH Herndon, JE D'Amico, TA
Citation: Ta. Aloia et al., Tumor marker expression is predictive of survival in patients with esophageal cancer, ANN THORAC, 72(3), 2001, pp. 859-866

Authors: Pai-Scherf, LH Carrasquillo, JA Paik, C Gansow, O Whatley, M Pearson, D Webber, K Hamilton, M Allegra, C Brechbiel, M Willingham, MC Pastan, I
Citation: Lh. Pai-scherf et al., Imaging and phase I study of In-111- and Y-90-labeled anti-Lewis(Y) monoclonal antibody B3, CLIN CANC R, 6(5), 2000, pp. 1720-1730

Authors: Richman, PB Dinowitz, S Nashed, AH Eskin, B Sylvan, E Allegra, C Allegra, J Mandell, M
Citation: Pb. Richman et al., The emergency department as a potential site for smoking cessation intervention: A randomized, controlled trial, ACAD EM MED, 7(4), 2000, pp. 348-353

Authors: Allegra, C Carlizza, A
Citation: C. Allegra et A. Carlizza, Oedema in chronic venous insufficiency: Physiopathology and investigation, PHLEBOLOGY, 15(3-4), 2000, pp. 122-125

Authors: Zajac-Kaye, M Ben-Baruch, N Kastanos, E Kaye, FJ Allegra, C
Citation: M. Zajac-kaye et al., Induction of Myc-intron-binding polypeptides MIBP1 and RFX1 during retinoic acid-mediated differentiation of haemopoietic cells, BIOCHEM J, 345, 2000, pp. 535-541

Authors: Kruger, EA Duray, PH Tsokos, MG Venzon, DJ Libutti, SK Dixon, SC Rudek, MA Pluda, J Allegra, C Figg, WD
Citation: Ea. Kruger et al., Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay, BIOC BIOP R, 268(1), 2000, pp. 183-191

Authors: Shapiro, JD Harold, N Takimoto, C Hamilton, JM Vaughn, D Chen, A Steinberg, SM Liewehr, D Allegra, C Monahan, B Lash, A Grollman, F Flemming, D Behan, K Johnston, PG Haller, D Quinn, M Morrison, G Grem, JL
Citation: Jd. Shapiro et al., A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma, CLIN CANC R, 5(9), 1999, pp. 2399-2408

Authors: Wolmark, N Bryant, J Smith, R Grem, J Allegra, C Hyams, D Atkins, J Dimitrov, N Oishi, R Prager, D Fehrenbacher, L Romond, E Colangelo, L Fisher, B
Citation: N. Wolmark et al., Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National surgical adjuvant breast and bowel project protocol C-05, J NAT CANC, 90(23), 1998, pp. 1810-1816
Risultati: 1-9 |